BIT’S 7th Annual Congress of International Drug Discovery Science and Technology

Hits:2186 Date: 8/18/2009

Theme: Milestones of Innovative Therapeutics

Time & Venue: October 22-25,2009
Everbright Convention & Exhibition Center , Shanghai , China

About IDDST

In 2009, this is an exciting time for those in drug discovery and development field once again. With the emphasis on the practical, actionable ideas for accelerating discovery and early development, the 7th congress will be the great opportunity for the world’s leading scientists and executives to share with you the latest advancements in viral studies and their strategic approaches to win the race to bring in the next blockbuster drug to market and milestones of innovative therapeutics. It encourages the mutual understanding between basic research and commercial purposes. It will be a unique conference place for updating both knowledge and translating cutting-edge scientific outcome and technology into industrial productivity for a new healthier world. Through IDDST congress 2009, you will gain a full coverage on the up-to-date with the booming drug R&D industry and its partnering potential in Asia, also deeply understand the market and current situation to get what you need, such as the strategies of major pharma players in integrating scientific, technological, talent and business resources in a flat world to increase business competitive capacities.

Schedule

IDDST 2009 is comprised of Eight Section s designed to offer comprehensive sessions that address current issues in Drug R&D and innovative therapeutics. You can register a whole conference or select a single Section or register for special service package that you want for your participation. Now the program is under developing from viewing submitted abstracts.

Chapter 1: Basic Sciences of Preclinical Studies
-Sciences is All We Need to Start

Chapter 2: Smart Drug Discovery Chemistry
-Applied Robust Chemistry to Better Molecules

Chapter 3: Methodology & Innovative tools for drug discovery, Drug delivery and Drug Development
-Master the Matured Cutting-Edge Technologies for Drug Innovations

Chapter 4: Translational Medicine
-Bridge Pharm R & D from Bench to Bedside

Chapter 5: Drug Discovery of Major Diseases
-Targeting Unsolved Life Threatening Diseases

Chapter 6: New Heats for Biotherapeutics
-Discover Humanized Natural Bio-Drugs

Chapter 7: Milestones of Novel Therapeutics Pipeline
-Update and Case Studies for Novel INDs on Trials

Chapter 8: Outsourcing, Partnership, and Licensing across the World
- Cost Effective and Result Driving Forces

Program Schedule

Time: October 22-25 Venue: Everbright Convention and Exhibition Center , Shanghai , China

Program		Time
	On-Site Registration	08:00-19:10 October 21-22, 2009
	Group Photo	08:20-08:40 October 22, 2009, Thursday
	Opening Ceremony & Keynote Forum	09:00-11:45 October 22, 2009, Thursday
	Welcome Banquet Sponsored b y Roche R&D Center ( China ) Ltd	18:00-21:00 October 22, 2009, Thursday
	Cocktail Party Sponsored b y Viva Biotech Ltd	18:00-20:00 October 23, 2009, Friday
Chapter 1: Basic Sciences of Preclinical Studies	Section 1-1: Oncology and Drug Discovery	13:30-17:10 October 22, 2009, Thursday
	Section 1-2: Inflammation and Drug Discovery	13:30-17:10 October 22, 2009, Thursday
	Section 1-3: Endocrinology and Drug Discovery	08:30-12:10 October 23, 2009, Friday
	Section 1-4: Immunology and Drug Discovery	08:30-12:10 October 23, 2009, Friday
	Section 1-5: Pharmacology, PK/PD and Drug Discovery	13:30-17:10 October 23, 2009, Friday
	Section 1-6: Toxicology and Drug Discovery	13:30-17:10 October 23, 2009, Friday
	Section 1-7: Molecular/Cell Biology and Drug Discovery	08:30-12:10 October 24, 2009, Saturday
	Section 1-8: Neurology and Drug Discovery	08:30-12:10 October 24, 2009, Saturday
	Section 1-9: Microbiology, Virology and Drug Discovery	13:30-17:10 October 24, 2009, Saturday
	Section 1-10: Hematology and Drug Discovery	13:30-17:10 October 24, 2009, Saturday
Chapter 2: Smart Drug Discovery Chemistry	Section 2-1: Receptors and Ion Channel Based Drug Design and Development	13:30-17:10 October 22, 2009, Thursday
	Section 2-2: Fragment Based Drug Design and Development	13:30-17:10 October 22, 2009, Thursday
	Section 2-3: RNA/DNA Structure-Based Drug Discovery Chemistry	08:30-12:10 October 23, 2009, Friday
	Section 2-4: Computer Aided Drug Design and SAR Studies	08:30-12:10 October 23, 2009, Friday
	Section 2-5: Virtual Screening to Combinatorial Chemistry for Hit Findings	13:30-17:10 October 23, 2009, Friday
	Section 2-6: Structure Biology Based Drug Design and Synthesis	13:30-17:10 October 23, 2009, Friday
	Section 2-7: Novel Methods for Lead Modification	08:30-12:10 October 24, 2009, Saturday
	Section 2-8: Organometallic Chemistry in Drug Development	08:30-12:10 October 24, 2009, Saturday
	Section 2-9: Improving ADME/DMPK Profile, Reducing DDI/Toxicity, and Overcoming Formulation Difficulties	08:30-12:10 October 25, 2009, Sunday
Chapter 3: Methodology & Innovative tools for drug discovery, Drug delivery and Drug Development	Section 3-1: Functional Genomics, Proteomics, Metabolomics, System Biology for Drug Discovery	13:30-17:10 October 22, 2009, Thursday
	Section 3-2: Molecular Target and Biomarkers for Drug Discovery	13:30-17:10 October 22, 2009, Thursday,
	Section 3-3: Biochips, Microarray and Molecular Imaging for Drug Discovery	08:30-12:10 October 23, 2009, Friday,
	Section 3-4: Bioinformatics/Chemoinformatics and Bio-IT/Pharm-IT for Drug Discovery	08:30-12:10 October 23, 2009, Friday,
	Section 3-5: RNAi, microRNA, and Non-Coding RNA Technologies	13:30-17:10 October 23, 2009, Friday
	Section 3-6: Cardiotoxicity / Hepatotoxicity and Drug Safety	13:30-17:10 October 24, 2009, Saturday
	Section 3-7: Cell-based to Tissue-based Assays	08:30-12:10 October 24, 2009, Saturday
	Section 3-8: High Content Imaging	13:30-17:10 October 24, 2009, Saturday
	Section 3-9: In Silico Models and Model Systems	08:30-12:10 October 25, 2009, Sunday
	Section 3-10: Nanotechnology and Novel Drug Delivery	08:30-12:10 October 25, 2009, Sunday
	Section 3-11: HPLC, LC-MS, Maldi-TOF and Structure Biology for Drug Discovery	08:30-12:10 October 25, 2009, Sunday
	Section 3-12: Pharmaceutical Analysis and Quality	13:30-17:10 October 23, 2009, Friday
	Section 3-13: Current Strategies of Bioequivalence & Bioavailability in Drug Development	13:30-17:10 October 22, 2009, Thursday
	Section 3-14: Recent Advances in Drug and Gene Delivery	08:30-12:10 October 24, 2009, Saturday
Chapter 4: Translational Medicine	Section 4-1: Translational Biomedicine and Multiplex Assays for the Progress of Translational Medicine	13:30-17:10 October 22, 2009, Thursday
	Section 4-2: Translational Medicine from Biomarkers, Molecular Profiling to Clinical Trials	08:30-12:10 October 23, 2009, Friday
	Section 4-3: Translational Oncology	13:30-17:10 October 24, 2009, Saturday
	Section 4-4: Translational Neurosciences	08:30-12:10 October 25, 2009, Sunday
Chapter 5: Drug Discovery of Major Diseases	Section 5-1: Anticancer Drug Discovery (Part I)	13:30-17:10 October 22, 2009, Thursday
	Section 5-2: Anti-Diabetes Drug Discovery	13:30-17:10 October 24, 2009, Saturday
	Section 5-3: Anti-Neurodegenerative Drug Discovery	08:30-12:10 October 23, 2009, Friday
	Section 5-4: Cardiovascular & Pulmonary Diseases and Drug Discovery	08:30-12:10 October 23, 2009, Friday
	Section 5-5: Anti-inflammation and Anti-autoimmune Diseases Drug Discovery	13:30-17:10 October 23, 2009, Friday
	Section 5-6: Anti-Bacterial & Antifungal Drug Discovery (Part I)	08:30-12:10 October 24, 2009, Saturday
	Section 5-7: Anti-Bacterial & Antifungal Drug Discovery (Part II)	13:30-17:10 October 24, 2009, Saturday
	Section 5-8: Anti-HIV Drug Discovery	08:30-12:10 October 25, 2009, Sunda
	Section 5-9: Anti-HCV Drug Discovery	08:30-12:10 October 25, 2009, Sunday
	Section 5-10: Gastrointestinal Drug Discoveries	08:30-12:10 October 25, 2009, Sunday
	Section 5-11: Anticancer Drug Discovery (Part II)	08:30-12:10 October 25, 2009, Sunday
Chapter 6: New Heats for Biotherapeutics	Section 6-1: Protein Based Biotherapeutics	13:30-17:10 October 22, 2009, Thursday
	Section 6-2: Monoclonal Antibody Based Biotherapeutics	08:30-12:10 October 23, 2009, Friday
	Section 6-3: Gene Therapeutics R & D	13:30-17:10 October 23, 2009, Friday
	Section 6-4: Cell Therapeutics and Regenerative Medicine	08:30-12:10 October 24, 2009, Saturday
	Section 6-5: Chemokine and Cytokine based Therapeutics	13:30-17:10 October 24, 2009, Saturday
	Section 6-6: Immunotherapy and Vaccine R & D	08:30-12:10 October 25, 2009, Sunday
Chapter 7: Milestones of Novel Therapeutics Pipeline	Section 7-1: Anticancer Pipeline Therapeutics	13:30-17:10 October 23, 2009, Friday
	Section 7-2: Anti-Infectious Therapeutics	08:30-12:10 October 24, 2009, Saturday
	Section 7-3: Anti-Diabetes Therapeutics	08:30-12:10 October 24, 2009, Saturday
	Section 7-4: Anti-CNS Disorder Therapeutics	13:30-17:10 October 24, 2009, Saturday
Chapter 8: Outsourcing, Partnership, and Licensing across the World	Section 8-1: Integrated Services & Partnership for Drug Discovery(Part I)	08:30-12:10 October 24, 2009, Saturday
	Section 8-2: Molecular Biology Outsourcing Alliance	13:30-17:10 October 23, 2009, Friday
	Section 8-3: PK/PD and Bioanalysis Outsourcing Alliance	08:30-12:10 October 25, 2009, Sunday
	Section 8-4: Clinical Trials Outsourcing Alliance and Regulatory Issues	13:30-17:10 October 25, 2009, Sunday
	Section 8-5: Integrated Services & Partnership for Drug Discovery (Part II)	13:30-17:30 October 24, 2009, Saturday
Poster-tour	Shanghai, Hangzhou, Wuzhen	10/26- 10/27/2009

BIT’ s Claims: All events BIT Life Sciences organized are purely for promotion of advancement of sciences and technologies for the sustainable development of a healthier and wealthier world. No political, religious racial bias and non-ethic knowledge are accepted through our intelligence exchange platform. Any illegal and offensive Information will be 100% avoided.

Scientific Program

Registration Now

Programmed Sessions at a Glance

Chapter 1: Basic Sciences of Preclinical Studies -Sciences is All We Need to Start	Chapter 5: Drug Discovery of Major Diseases -Targeting Unsolved Life Threatening Diseases
Chapter 2 ： Smart Drug Discovery Chemistry -Applied Robust Chemistry to Better Molecules	Chapter 6: New Heats for Biotherapeutics -Discover Humanized Natural Bio-Drugs
Chapter 3: Methodologies & Innovative Tools for Drug Discovery, Drug Delivery and Drug Development -Master the Matured Cutting-Edge Technologies for Drug Innovations	Chapter 7: Milestones of Novel Therapeutics Pipeline -Update and Case Studies for Novel INDs on Trials
Chapter 4: Translational Medicine -Bridge Pharm R & D from Bench to Bedside	Chapter 8: Outsourcing, Partnership, and Licensing across the World - Cost Effective and Result Driving Forces

Key Dates

Important Deadlines
10 September 2008	Start date for online/hard copy Abstract Submissions
15 September 2008	Start date for online Early Bird registrations
31 January 2009	End date for online Early Bird registrations
5 July 2009	End date of BIT members’ discounted registration rate
20 August 2009	End date for Abstract submissions
20 August 2009	End date of Abstract review process
30 September 2009	End date of Hotel Accommodation Cancellation
20 September 2009	End date of Mailing of Abstract notification letters
25 September 2009	End date of requests for Letter of Invitation for visa application
1 October 2009	Deadline for cancellation of social program and tours
15 October 2009	End date of regular registration
22 October 2009	Congress Opening Ceremony

The History of IDDST

The congress of IDDST, initiated by BIT Life Sciences in 2003, has offered a unique across cultural meeting place of drug discovery in China . In the past six years, the congresses of IDDST have attracted more than world renowned speakers with over 40,000 professionals around the world as a leading international event for the professionals to sharing scientific information and seeking business opportunities in drug discovery fields through the annual congress and our tech tour programs in different cities of China . Many world prominent scientists, senior executives, entrepreneurs, and investors have joined us enthusiastically with diversified contributions to each congress of IDDST. You may find the Collection of previous conferences as following.

IDDST2008
IDDST2007
IDDST2006
IDDST2005
IDDST2004

Exhibition at IDDST Congress

IDDST Congress 2009 is your best chance to showcase to drug discovery professionals in China . Developed to offer comfort to delegates while maximizing exhibitor exposure, the coffee break, and poster sessions will all take place in the exhibition area promoting frequent repeated opportunities for delegates to visit the exhibits. The IDDST 2009 will take place at Shanghai Everbright Convention and Exhibition Center . Lectures will be held on the 2 nd floor of the build, immediately close to the exhibition area.

Sponsorship

Why should you sponsor this event?

IDDST Congress 2009 is where your clients will come to look for solutions you can provide.
The event will offer a variety of conference and networking formats including; workshops, plenary sessions, parallel sessions, speed networking and a sociable drinks reception.

As a sponsor of this event you will be able to consider the most appropriate way to present your products and services and select a sponsorship package that is best suited to your marketing objectives and your preferred communication style. This event will deliver an excellent marketing and networking opportunity. By sponsoring or exhibiting at this event you will:

Learn from top level speakers
Uncover new opportunities and generate leads
Gain access to your target market
Integrate with the outsourcing and operations community
Enhance your brand and market position
Showcase your products and services

Offical Website: www.iddst.com

Contact

For Program and Sponsors:
Annie Sun
Organizing Committee of IDDST Congress
26 Gaoneng St., R401
Dalian Hightech Zone
Dalian, LN 116025, China
Tel: 0086-411-84799479
Fax: 0086-411-84799629
Email: annie@iddst.com

For Attendees and Media Partners:
Sean Song
Organizing Committee of IDDST Congress
26 Gaoneng St., R401
Dalian Hightech Zone
Dalian, LN 116025, China
Tel: 0086-411-84799479
Fax: 0086-411-84799629
Email: sean@iddst.com